Imitrex (2013-11-01)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| C632842 | Imitrex | - Recalling Firm
- GlaxoSmithKline Inc.
- 7333 Mississauga Road North
- Mississauga
- L5N 6L4
- Ontario
- CANADA
- Marketing Authorization Holder
- GlaxoSmithKline Inc.
- 7333 Mississauga Road North
- Mississauga
- L5N 6L4
- Ontario
- CANADA
| Injection | DIN 02212188 | 12 mg/mL |
Recalled products
Imitrex
The above two batches of Imitrex pre-filled syringes were packaged with needles that may have protruded through the needle shield.
Wholesalers, hospitals, pharmacies across Canada